Profile | GDS4284 / 233287_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 43.2245 | 23 |
GSM687648 | Patient 402 control | 49.876 | 23 |
GSM687653 | Patient 403 control | 63.4251 | 27 |
GSM687658 | Patient 404 control | 156.113 | 43 |
GSM687663 | Patient 411 control | 81.3644 | 29 |
GSM687668 | Patient 422 control | 48.9829 | 23 |
GSM687673 | Patient 424 control | 57.7773 | 24 |
GSM687678 | Patient 425 control | 83.6354 | 30 |
GSM687683 | Patient 427 control | 192.976 | 45 |
GSM687688 | Patient 428 control | 76.4559 | 30 |
GSM687695 | Patient 441 control | 870.582 | 73 |
GSM687699 | Patient 443 control | 175.636 | 42 |
GSM687704 | Patient 444 control | 46.3061 | 22 |
GSM687707 | Patient 448 control | 167.063 | 41 |
GSM687712 | Patient 449 control | 185.248 | 46 |
GSM687719 | Patient 450 control | 67.7026 | 24 |
GSM687724 | Patient 451 control | 234.014 | 49 |
GSM687728 | Patient 452 control | 56.3624 | 23 |
GSM687646 | Patient 401 treated 24h | 52.8766 | 24 |
GSM687649 | Patient 402 treated 24h | 40.0481 | 22 |
GSM687665 | Patient 411 treated 24h | 118.016 | 35 |
GSM687651 | Patient 402 treated 4 weeks | 90.843 | 31 |
GSM687667 | Patient 411 treated 4 weeks | 56.0795 | 24 |
GSM687670 | Patient 422 treated 24h | 110.186 | 35 |
GSM687671 | Patient 422 treated 4 weeks | 50.3489 | 24 |
GSM687654 | Patient 403 treated 24h | 59.6423 | 27 |
GSM687675 | Patient 424 treated 24h | 73.0835 | 27 |
GSM687685 | Patient 427 treated 24h | 42.7015 | 21 |
GSM687656 | Patient 403 treated 4 weeks | 52.6532 | 26 |
GSM687677 | Patient 424 treated 4 weeks | 33.5589 | 18 |
GSM687687 | Patient 427 treated 4 weeks | 32.0492 | 19 |
GSM687692 | Patient 428 treated 4h | 108.586 | 36 |
GSM687716 | Patient 449 treated 4h | 75.2978 | 29 |
GSM687722 | Patient 450 treated 4h | 81.8964 | 28 |
GSM687680 | Patient 425 treated 24h | 56.7778 | 25 |
GSM687690 | Patient 428 treated 24h | 52.6769 | 24 |
GSM687700 | Patient 443 treated 24h | 108.428 | 28 |
GSM687705 | Patient 444 treated 24h | 120.34 | 40 |
GSM687714 | Patient 449 treated 24h | 35.7545 | 20 |
GSM687721 | Patient 450 treated 24h | 143.594 | 37 |
GSM687682 | Patient 425 treated 4 weeks | 99.8506 | 35 |
GSM687694 | Patient 428 treated 4 weeks | 88.5133 | 34 |
GSM687702 | Patient 443 treated 4 weeks | 87.2662 | 30 |
GSM687718 | Patient 449 treated 4 weeks | 36.1208 | 18 |
GSM687723 | Patient 450 treated 4 weeks | 62.1903 | 25 |
GSM687661 | Patient 404 treated 4h | 125.351 | 38 |
GSM687710 | Patient 448 treated 4h | 98.9643 | 34 |
GSM687726 | Patient 451 treated 4h | 34.1542 | 17 |
GSM687730 | Patient 452 treated 4h | 1033.35 | 74 |
GSM687660 | Patient 404 treated 24h | 150.098 | 37 |
GSM687697 | Patient 441 treated 24h | 190.376 | 41 |
GSM687709 | Patient 448 treated 24h | 119.596 | 36 |
GSM687725 | Patient 451 treated 24h | 144.546 | 37 |
GSM687729 | Patient 452 treated 24h | 132.278 | 33 |
GSM687727 | Patient 451 treated 4 weeks | 91.846 | 29 |
GSM687731 | Patient 452 treated 4 weeks | 53.075 | 21 |